Pharmatech. In the 64th Conference of the Foundation for Health Research (FUINSA), entitled "Biosimilar Medicines: Access to Clinical Practice" and held on November 3, different representatives of scientific societies, the Health Administration, and patients expressed their perspectives on biological medicines in the different specialties, and the incorporation of biosimilar medicines.